LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

about

TGFβ Controls Ovarian Cancer Cell Proliferation Murine Precision-Cut Kidney Slices as an ex vivo Model to Evaluate the Role of Transforming Growth Factor-β1 Signaling in the Onset of Renal Fibrosis.Targeting the Microenvironment in High Grade Serous Ovarian Cancer

P2860

Q41573289-B279DFF7-13AD-485D-8BEB-A3898142723B Q47221971-9C7B6DFA-4E02-4FB3-B6B5-DB5418DC40D2 Q58789499-D8014409-9CCF-4874-9863-32B04119A4A9

P2860

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

Item

http://www.wikidata.org/entity/Q35854002

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

@ast

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

@en

type

Item

label

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

@ast

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

@en

prefLabel

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

@ast

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

@en

P1476

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells

@en

P2093

Cheng Zhao

http://www.w3.org/2001/XMLSchema#string

Fuliang Xu

http://www.w3.org/2001/XMLSchema#string

Jiacun Li

http://www.w3.org/2001/XMLSchema#string

Lifeng Gao

http://www.w3.org/2001/XMLSchema#string

Ning Shan

http://www.w3.org/2001/XMLSchema#string

Xiaoqian Yu

http://www.w3.org/2001/XMLSchema#string

Yunhai Wang

http://www.w3.org/2001/XMLSchema#string

Yuxiu Gao

http://www.w3.org/2001/XMLSchema#string

Zhengjun Yi

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

Cancer statistics, 2012

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence

Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors

Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner.

TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.

Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.

TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment

Pharmacological induction of transforming growth factor-beta1 in rat models enhances radiation injury in the intestine and the heart

P304

4923-4932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26191185

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

4503057

http://www.w3.org/2001/XMLSchema#string

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

about

P2860

P2860

LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932